By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Valeant Pharmaceuticals International 

Worldwide Headquarters
One Enterprise
Aliso Viejo  California  92656  U.S.A.
Phone: 800-548-5100 or 949-461-6000 Fax: 714-556-0131


SEARCH JOBS


Industry
Pharmaceutical


Collaborations

Metabasis Therapeutics, Inc.  – Hepatitis B





Company News
Valeant (VRX) CEO Fesses Up to What Went Wrong in Pursuit of Allergan (AGN) 1/22/2015 6:41:15 AM
Valeant (VRX) Announces Redemption Of All Of The Approximately $500 Million Aggregate Principal Amount Of Its Outstanding 6.875% Senior Notes Due 2018 1/16/2015 7:51:40 AM
Valeant (VRX) Announces Pricing Of Private Offering Of Senior Notes 1/16/2015 7:50:26 AM
Valeant (VRX) Announces Launch Of Private Offering Of Senior Notes 1/15/2015 10:34:25 AM
J.P. Morgan: Valeant (VRX) Investors Should Expect "Small and Medium Sized" Deals in 2015, Says CFO 1/13/2015 10:09:07 AM
Valeant (VRX) To Present At The J.P. Morgan 2015 Healthcare Conference 1/6/2015 1:51:03 PM
Valeant (VRX) Possibly Eyeing Dental Device Makers Such as Align Technology, Inc. (ALGN) and DENTSPLY International Inc. (XRAY) in 2015: Analysts 12/31/2014 6:16:55 AM
Valeant (VRX) To Hold Conference Call To Announce 2015 Financial Guidance 12/16/2014 9:24:35 AM
Valeant (VRX) To Drop Deal-Making To Cut Debt, Boost Stock 12/10/2014 6:54:08 AM
Valeant (VRX) Announces Redemption Of US$445.0 Million Aggregate Principal Amount Of Its Outstanding 6.875% Senior Notes Due 2018 12/1/2014 12:48:22 PM
12345678910...
//-->